Interlacing the relevance of caspase activation in the onset and progression of Alzheimer's disease

Brain Res Bull. 2023 Jan:192:83-92. doi: 10.1016/j.brainresbull.2022.11.008. Epub 2022 Nov 11.

Abstract

Caspases, a family of cysteine proteases is a renowned regulator of apoptosis. Members of this family are responsible for the proteolytic dismantling of numerous cellular structures. Apart from apoptosis, caspases remarkably contribute to a diverse range of molecular processes. Being the imperative members of several cellular cascades their abnormal activation/deactivation has severe implications and also leads to various diseased conditions. Similar aberrant activation of caspases is one of the several causes of neuropathologies associated with Alzheimer's disease (AD), a form of dementia severely affecting neuropsychiatric and cognitive functions. Emerging studies are providing deeper insights into the mechanisms of caspase action in the progression of AD. Current article is an attempt to review these studies and present the action mechanisms of different mammalian caspases in the advancement of AD associated neuropathologies.

Keywords: Alzheimer disease; Amyloid beta; Apoptosis; Caspases; Microglial activation; Tau.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / pathology
  • Animals
  • Apoptosis / physiology
  • Caspase 3
  • Caspases / metabolism
  • Humans
  • Mammals / metabolism
  • Protein Processing, Post-Translational
  • Proteolysis

Substances

  • Caspases
  • Caspase 3